Skip to main content
Erschienen in: Journal of Neuro-Oncology 3/2011

01.07.2011 | Case Report

Progressive multifocal leukoencephalopathy in a patient with glioblastoma

verfasst von: Jing Wu, Lauren A. Langford, Dawid Schellingerhout, Nandita Guha-Thakurta, Sudhakar Tummala, Jeffrey S. Weinberg, Vinay K. Puduvalli

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Malignant gliomas are aggressive malignancies which inevitably recur despite multimodality treatment. In a subset of patients who are longer term survivors of this disease, progressive radiologic worsening can also occur from late effects of radiation rather than recurrent tumor, a differential diagnosis that is commonly considered in this setting. However, other causes for radiologic progression are not as well recognized and could potentially confound management leading to incorrect treatment decisions. Progressive multifocal leukoencephalopathy (PML) is a rare infectious demyelinating disease of the central nervous system seen primarily in immunocompromised patients, the early diagnosis and treatment of which remains a challenge. Here, we report a case of a long term survivor with glioblastoma whose diagnostic and therapeutic management was confounded by the development of PML. We review the radiological features and clinical course of this patient to highlight the dramatic neurological course in the setting of a highly malignant tumor, and emphasize the unusual changes in diffusion weighted images, and the need for clinical suspicion for early diagnosis of PML.
Literatur
1.
Zurück zum Zitat Astrom KE, Mancall EL, Richardson EP Jr (1958) Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin’s disease. Brain 81:93–111PubMedCrossRef Astrom KE, Mancall EL, Richardson EP Jr (1958) Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin’s disease. Brain 81:93–111PubMedCrossRef
2.
Zurück zum Zitat Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH (1971) Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1:1257–1260PubMedCrossRef Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH (1971) Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1:1257–1260PubMedCrossRef
3.
Zurück zum Zitat Weber T, Trebst C, Frye S, Cinque P, Vago L, Sindic CJ, Schulz-Schaeffer WJ, Kretzschmar HA, Enzensberger W, Hunsmann G, Luke W (1997) Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis 176:250–254PubMedCrossRef Weber T, Trebst C, Frye S, Cinque P, Vago L, Sindic CJ, Schulz-Schaeffer WJ, Kretzschmar HA, Enzensberger W, Hunsmann G, Luke W (1997) Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis 176:250–254PubMedCrossRef
4.
Zurück zum Zitat Maginnis MS, Atwood WJ (2009) JC virus: an oncogenic virus in animals and humans? Semin Cancer Biol 19:261–269PubMedCrossRef Maginnis MS, Atwood WJ (2009) JC virus: an oncogenic virus in animals and humans? Semin Cancer Biol 19:261–269PubMedCrossRef
5.
Zurück zum Zitat Kato A, Kitamura T, Takasaka T, Tominaga T, Ishikawa A, Zheng HY, Yogo Y (2004) Detection of the archetypal regulatory region of JC virus from the tonsil tissue of patients with tonsillitis and tonsilar hypertrophy. J Neurovirol 10:244–249PubMedCrossRef Kato A, Kitamura T, Takasaka T, Tominaga T, Ishikawa A, Zheng HY, Yogo Y (2004) Detection of the archetypal regulatory region of JC virus from the tonsil tissue of patients with tonsillitis and tonsilar hypertrophy. J Neurovirol 10:244–249PubMedCrossRef
6.
Zurück zum Zitat Koralnik IJ, Schellingerhout D, Frosch MP (2004) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14–2004. A 66 year-old man with progressive neurologic deficits. N Engl J Med 350:1882–1893PubMedCrossRef Koralnik IJ, Schellingerhout D, Frosch MP (2004) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14–2004. A 66 year-old man with progressive neurologic deficits. N Engl J Med 350:1882–1893PubMedCrossRef
7.
Zurück zum Zitat Morriss MC, Rutstein RM, Rudy B, Desrochers C, Hunter JV, Zimmerman RA (1997) Progressive multifocal leukoencephalopathy in an HIV-infected child. Neuroradiology 39:142–144PubMedCrossRef Morriss MC, Rutstein RM, Rudy B, Desrochers C, Hunter JV, Zimmerman RA (1997) Progressive multifocal leukoencephalopathy in an HIV-infected child. Neuroradiology 39:142–144PubMedCrossRef
8.
Zurück zum Zitat Shitrit D, Lev N, Bar-Gil-Shitrit A, Kramer MR (2005) Progressive multifocal leukoencephalopathy in transplant recipients. Transpl Int 17:658–665PubMedCrossRef Shitrit D, Lev N, Bar-Gil-Shitrit A, Kramer MR (2005) Progressive multifocal leukoencephalopathy in transplant recipients. Transpl Int 17:658–665PubMedCrossRef
9.
Zurück zum Zitat Hecht JH, Glenn OA, Wara DW, Wu YW (2007) JC virus granule cell neuronopathy in a child with CD40 ligand deficiency. Pediatr Neurol 36:186–189PubMedCrossRef Hecht JH, Glenn OA, Wara DW, Wu YW (2007) JC virus granule cell neuronopathy in a child with CD40 ligand deficiency. Pediatr Neurol 36:186–189PubMedCrossRef
10.
Zurück zum Zitat Yokoyama H, Watanabe T, Maruyama D, Kim SW, Kobayashi Y, Tobinai K (2008) Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature. Int J Hematol 88:443–447PubMedCrossRef Yokoyama H, Watanabe T, Maruyama D, Kim SW, Kobayashi Y, Tobinai K (2008) Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature. Int J Hematol 88:443–447PubMedCrossRef
11.
Zurück zum Zitat Chowdhary S, Chamberlain M (2008) A progressive neurologic disorder with multiple CNS lesions: a neuroimaging clinicopathologic correlation. Progressive multifocal leukoencephalopathy (PML). J Neuroimaging 18:340–344PubMedCrossRef Chowdhary S, Chamberlain M (2008) A progressive neurologic disorder with multiple CNS lesions: a neuroimaging clinicopathologic correlation. Progressive multifocal leukoencephalopathy (PML). J Neuroimaging 18:340–344PubMedCrossRef
12.
Zurück zum Zitat Berger JR, Concha M (1995) Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J Neurovirol 1:5–18PubMedCrossRef Berger JR, Concha M (1995) Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J Neurovirol 1:5–18PubMedCrossRef
13.
Zurück zum Zitat Fong IW, Britton CB, Luinstra KE, Toma E, Mahony JB (1995) Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 33:484–486PubMed Fong IW, Britton CB, Luinstra KE, Toma E, Mahony JB (1995) Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 33:484–486PubMed
14.
Zurück zum Zitat Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR (1992) Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5:49–73PubMed Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR (1992) Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5:49–73PubMed
15.
Zurück zum Zitat Post MJ, Yiannoutsos C, Simpson D, Booss J, Clifford DB, Cohen B, McArthur JC, Hall CD (1999) Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS clinical trials group, 243 team. AJNR Am J Neuroradiol 20:1896–1906PubMed Post MJ, Yiannoutsos C, Simpson D, Booss J, Clifford DB, Cohen B, McArthur JC, Hall CD (1999) Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS clinical trials group, 243 team. AJNR Am J Neuroradiol 20:1896–1906PubMed
16.
Zurück zum Zitat Carson KR, Focosi D, Major EO, Petrini M, Richey EA, West DP, Bennett CL (2009) Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the research on adverse drug events and reports (RADAR) project. Lancet Oncol 10:816–824PubMedCrossRef Carson KR, Focosi D, Major EO, Petrini M, Richey EA, West DP, Bennett CL (2009) Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the research on adverse drug events and reports (RADAR) project. Lancet Oncol 10:816–824PubMedCrossRef
17.
Zurück zum Zitat Dworkin MS (2002) A review of progressive multifocal leukoencephalopathy in persons with and without AIDS. Curr Clin Top Infect Dis 22:181–195PubMed Dworkin MS (2002) A review of progressive multifocal leukoencephalopathy in persons with and without AIDS. Curr Clin Top Infect Dis 22:181–195PubMed
18.
Zurück zum Zitat Hall CD, Dafni U, Simpson D, Clifford D, Wetherill PE, Cohen B, McArthur J, Hollander H, Yainnoutsos C, Major E, Millar L, Timpone J (1998) Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS clinical trials group 243 team. N Engl J Med 338:1345–1351PubMedCrossRef Hall CD, Dafni U, Simpson D, Clifford D, Wetherill PE, Cohen B, McArthur J, Hollander H, Yainnoutsos C, Major E, Millar L, Timpone J (1998) Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS clinical trials group 243 team. N Engl J Med 338:1345–1351PubMedCrossRef
19.
Zurück zum Zitat Bauer WR, Turel AP Jr, Johnson KP (1973) Progressive multifocal leukoencephalopathy and cytarabine. Remission with treatment. JAMA 226:174–176PubMedCrossRef Bauer WR, Turel AP Jr, Johnson KP (1973) Progressive multifocal leukoencephalopathy and cytarabine. Remission with treatment. JAMA 226:174–176PubMedCrossRef
Metadaten
Titel
Progressive multifocal leukoencephalopathy in a patient with glioblastoma
verfasst von
Jing Wu
Lauren A. Langford
Dawid Schellingerhout
Nandita Guha-Thakurta
Sudhakar Tummala
Jeffrey S. Weinberg
Vinay K. Puduvalli
Publikationsdatum
01.07.2011
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 3/2011
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-010-0453-9

Weitere Artikel der Ausgabe 3/2011

Journal of Neuro-Oncology 3/2011 Zur Ausgabe

Clinical Study – Patient Study

Recurrence in childhood medulloblastoma

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.